Tech Company Financing Transactions

Essentialis Funding Round

Essentialis secured a Series B financing round on 10/11/2010. Investors included Forward Ventures, Palo Alto Investors and Technology Partners.

Transaction Overview

Company Name
Announced On
10/11/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors

Forward Ventures (Stuart Collinson)

Palo Alto Investors

Technology Partners (James Glasheen)

Vivo Capital (James Huang)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2011 Palomar Airport Rd. 108
Carlsbad, CA 92011
USA
Email Address
Overview
Essentialis is a pharmaceutical company focused on the development of breakthrough medicines for the treatment of cardiovascular and metabolic diseases.
Profile
Essentialis LinkedIn Company Profile
Social Media
Essentialis Company Twitter Account
Company News
Essentialis News
Facebook
Essentialis on Facebook
YouTube
Essentialis on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Neil Cowen
  Neil Cowen LinkedIn Profile  Neil Cowen Twitter Account  Neil Cowen News  Neil Cowen on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/11/2010: BioSystem Development venture capital transaction
Next: 10/11/2010: TriReme Medical venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary